The store will not work correctly when cookies are disabled.
1-(7-chloro-4-methylquinazolin-2-yl)-3-(3-(dimethylamino)phenyl)guanidine
ID: ALA5220879
PubChem CID: 168298530
Max Phase: Preclinical
Molecular Formula: C18H19ClN6
Molecular Weight: 354.85
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc(NC(=N)Nc2cccc(N(C)C)c2)nc2cc(Cl)ccc12
Standard InChI: InChI=1S/C18H19ClN6/c1-11-15-8-7-12(19)9-16(15)23-18(21-11)24-17(20)22-13-5-4-6-14(10-13)25(2)3/h4-10H,1-3H3,(H3,20,21,22,23,24)
Standard InChI Key: JKMSDBVMGKHNMW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-3.9293 0.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2147 0.8230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5028 0.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5028 -0.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2129 -0.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9293 -0.4177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6439 -0.8303 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 -0.8281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0734 -0.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0752 0.4094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7901 0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7901 1.6471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3587 -0.8241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 -0.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0704 -0.8241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 -0.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 0.4136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7853 0.4137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4982 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2130 0.4117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2146 -0.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5028 -0.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 -0.8219 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6439 -0.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 -1.6471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
4 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
3 11 1 0
11 12 1 0
9 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 2 0
18 16 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
16 22 1 0
21 23 1 0
23 24 1 0
23 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.85 | Molecular Weight (Monoisotopic): 354.1360 | AlogP: 4.12 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.93 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.84 | CX LogP: 4.11 | CX LogD: 4.09 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.49 | Np Likeness Score: -1.60 |
References
1. Morrill C, Friesen WJ, Babu S, Baiazitov RY, Du W, Karloff DB, Lee CS, Moon YC, Ren H, Sierra J, Tomizawa Y, Vazirani P, Welch EM, Xue X, Zhuo J.. (2022) Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations., 76 [PMID:36150638] [10.1016/j.bmcl.2022.128989] |